{
    "paper_id": "fac9ef6ba1ca4bdb16baad83f0146e6a5c3b906f",
    "metadata": {
        "title": "European Journal of Immunology Supporting Information for Conditional ligands for Asian HLA variants facilitate the definition of CD8 + T-cell responses in acute and chronic viral diseases",
        "authors": [
            {
                "first": "Cynthia",
                "middle": [
                    "X L"
                ],
                "last": "Chang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Anthony",
                "middle": [
                    "T"
                ],
                "last": "Tan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ming",
                "middle": [
                    "Yan"
                ],
                "last": "Or",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kai",
                "middle": [
                    "Yee"
                ],
                "last": "Toh",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Pei",
                "middle": [
                    "Yiing"
                ],
                "last": "Lim",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Adeline",
                "middle": [
                    "S E"
                ],
                "last": "Chia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Thomas",
                "middle": [
                    "M"
                ],
                "last": "Froesig",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Karen",
                "middle": [
                    "D"
                ],
                "last": "Nadua",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hsueh-Ling",
                "middle": [
                    "J"
                ],
                "last": "Oh",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Nam",
                "middle": [],
                "last": "Leong",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Sine",
                "middle": [
                    "R"
                ],
                "last": "Hadrup",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Adam",
                "middle": [
                    "J"
                ],
                "last": "Gehring",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yee-Joo",
                "middle": [],
                "last": "Tan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Antonio",
                "middle": [],
                "last": "Bertoletti",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Gijsbert",
                "middle": [
                    "M"
                ],
                "last": "Grotenbreg",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "A Supporting Information Figure 1 A. Design of 9-, 10-, 11-mer peptides derived from the 15-mer antigen. Overlapping 9-, 10-, 11-mer peptides were each tested for their capability to stabilize the corresponding HLA. A total of 18 different peptides were derived from each 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 25,
                    "end": 33,
                    "text": "Figure 1",
                    "ref_id": null
                }
            ],
            "section": "Abstract"
        },
        {
            "text": "B. HLA-stability ELISA results for soluble HLA-B*40:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from SARS NP44 15-mer peptide. Non-irradiated HLA with conditional ligand and no peptide added (-UV), irradiated HLA and no peptide added (+UV), or with indicated 9-, 10-, 11-mers peptides. Peptides are labeled as capable (red bars) or incapable (white bars) of stabilizing the corresponding HLA.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "C. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*40:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from SARS NP65 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "D. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*55:02 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from DENV NS3-108 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "E. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*58:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from SARS 3a2 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "F. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*58:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from HBV Pol33 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "G. Similar to Part B, HLA-stability ELISA results for soluble HLA-B*58:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from HBV Env72 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "H.Similar to Part B, HLA-stability ELISA results for soluble HLA-C*08:01 molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from HBV Env34 15-mer peptide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "I. HLA-stability ELISA results for soluble HLA molecules that were ligand-exchanged with 9-, 10-, 11-mers truncated peptides from the indicated15-mer peptide. Non-irradiated HLA with conditional ligand and no peptide added (-UV), irradiated HLA and no peptide added (+UV), or with indicated 9-, 10-, 11-mers peptides.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "IT-TOF. The mass to charge ratios (m/z) of peptides were measured after liquid chromatography (LC) separation on a C18 column. As both isomers of the photocleavable 3-amino-3-(2nitro) phenyl-propanoic acid (Anp) used during solid phase peptide synthesis of the conditional ligand, 2 diasteroisomers could usually be identified. In some cases, however, the two isomers failed to separate during chromatography. The data displayed is for one of the two isomers, mostly for doubly charged molecules (M 2+ ), together with the amino acid sequences of conditional ligands where the letter J represents Anp.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Mass spectrometry (MS) analysis with isotopic distribution of conditional ligands by LCMS-"
        },
        {
            "text": "A. Cells were first analyzed for their size and granularity based on their forward scatter area (FSC-A) and side scatter area (SSC-A) profile. Doublets were excluded using side-scatter height (SSC-H) vs side-scatter width (SSC-W) and forward-scatter height (FSC-H) vs forwardscatter width (FSC-W) parameters. Cells present in all three gates were analyzed for their time vs forward scatter area (FSC-A) to exclude cells that were read at the beginning and end of the flow cytometry run. Viable cells were gated based on their negative staining with the Live/Dead\u00ae dye (Invitrogen), and these cells were finally analyzed for anti-human CD8 antibodies and HLA-tetramer stainings. All data were analyzed using FlowJo (Tree Star C. Culturing of PBMCs to develop antigen-specific T cell lines. PBMCs isolated from healthy volunteers' blood were stimulated by antigens from EBV-LMP2419-427 (TYGPVFMSL) or HCMV-IE-142-50 (KEVNSQLSL) and cultured in 25 U/mL IL-2, 5% AB serum in RPMI for 14 days. HLA tetramer staining for antigen-specific T cells was performed on day 0, 7, 10 and 14 days post stimulation. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Mass spectrometry (MS) analysis with isotopic distribution of conditional ligands by LCMS-"
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12",
            "authors": [],
            "year": null,
            "venue": "J Immunol",
            "volume": "164",
            "issn": "",
            "pages": "6041--6045",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol-and Gag-derived cytotoxic T cell epitopes",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Hossain",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tomiyama",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Inagawa",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ida",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Oka",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takiguchi",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "AIDS Res Hum Retroviruses",
            "volume": "19",
            "issn": "",
            "pages": "503--510",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ichiki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takenoyama",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mizukami",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "So",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sugaya",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Yasuda",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hanagiri",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sugio",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yasumoto",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Immunol",
            "volume": "172",
            "issn": "",
            "pages": "4844--4850",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Identification of the HLA-Cw*0702-restricted tumorassociated antigen recognized by a CTL clone from a lung cancer patient",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Nagata",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hanagiri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Takenoyama",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Fukuyama",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mizukami",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "So",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ichiki",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sugaya",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sugio",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yasumoto",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Cancer Res",
            "volume": "11",
            "issn": "",
            "pages": "5265--5272",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sidney",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Del Guercio",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Southwood",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hermanson",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Maewal",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Appella",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sette",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Hum Immunol",
            "volume": "58",
            "issn": "",
            "pages": "12--20",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "11:01-p3 (AI-J-QSSMTK) A*11:01-p4 (AIF-J-SSMTK) *11:01-p7 (AIFQSS-J-TK) A*24:02 -p4 (VYG-J-VRACL) A*33:03 -p2 (F-J-VDGAANR) A*33:03 -p4 (FYV-J-GAANR) 15:02 -p5 (ILGP-J-GSVY) B*15:02 -p7 (ILGPPG-J-VY) *40:01-p6 (TEADV-J-QWL) B*40:01-p7 (TEADVQ-J-WL) B*40:01-p8 (TEADVQQ-J-L) B*46:01-p4 (KMK-J-IAEAY) Design of UV-sensitive conditional ligands.A single amino acid within peptides capable of binding the respective HLA molecules was replaced with 3-amino-3-(2-nitro) phenyl-propanoic acid (Anp) at the position indicated by the filled black circle (\uf06c). Amino acid position 1 at the N-terminus to position 10 at the C-terminus are indicated by p1 to p10, respectively. These ligands were synthesized by solid phase peptide synthesis and used for refolding reactions. The yield represented by the weight of homogenous HLA monomer per litre of refolding reaction, was listed. When multiple conditional ligands were designed, such as in HLA-A*02:07, -A*11:01, -A*33:03 -B*15:02, -B*40:01, -B*46:01, ligands with the highest yield were selected for further studies (shaded grey).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Direct ex-vivo HLA tetramer staining of PBMCs from various HLA-matched volunteers. PBMCs were isolated and stained with HLA tetramers, followed by flow cytometry analysis. Peptides originating from HCMV-pp65 495-503 (NLVPMVATV), HBV-Core 18-27 (FLPSDFFPSV), EBV-EBNA4-NP 399-408 (AVFDRKSDAK), Influenza A-MP 13-21 (SIIPSGPLK), EBV-BRLF1 134-142 (ATIGTAMYK), EBV-LMP2 419-427 (TYGPVFMSL), HCMV-pp65 341-349 (QYDPVAALF), HCMV-pp65 91-100 (SVNVHNPTGR), EBV-EBNA3B 831-839 (GQGGSPTAM), HCMV-pp65 267-275 (HERNGFTVL), HCMV-IE-1 42-50 (KEVNSQLSL), HCMV-pp65 232-240 (CEDVPSGKL), DENVpp 2822-2830 (KPWDIIPMV), Influenza A-NP 199-207 (RGINDRNFW), EBV-LMP1 156-164 (IALYLQQNW), EBV-EBNA3B 279-287 (VSFIEFVGW) were used in the construction of tetramers for HLA-A*02:01, -A*02:06, -A*02:07, -A*11:01, -A*24:02, -A*33:03, -B*15:02, -B*40:01, -B*55:02 or -B*58:01 as indicated. For the generation of HLA-A*33:03 tetramers, conditional ligands with the photocleavable moiety at position 8 instead of position 4 was used.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": [
        {
            "text": "The HLA genes were cloned into pET-28a(+) vector at the NcoI (CCATGG) and BamHI (GGATCC) sites. The restriction sites (underline) and cloning overhangs (red text) are indicated. These genes were optimized for E.coli expression by GenScript (Piscataway, NJ). Plamids containing the gene for HLA-A*11:01 (PTCF48) and HLA-A*24:02 (PTCF6) were gifts from the NIH tetramer core facility, and the plasmid sequences can be found in http://tetramer.yerkes.emory.edu/client/protocols#1. The translated products are indicated below each optimized gene sequence.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "acknowledgement"
        },
        {
            "text": "Previously discovered antigenic peptides that were employed to generate HLAs monomers or tetramers by UV-mediated peptide exchange and the assays used for their identification(+) (Heidecker et al, 2000; Ichiki et al, 2004; Nagata et al, 2005 ) (Immune epitope database. URL: http://www.immuneepitope.org/). [3H]-TdR indicates 3Hthymidine cell proliferation; 51Cr killing, 51 Chromium release killing; ELISA, IFN-\u03b3 based enzyme-linked immunosorbent assay; ELISPOT, IFN-\u03b3 based enzyme-linked immunosorbent spot assay; ICS, intracellular cytokine staining for IFN-\u03b3; Tetramer, HLA tetramer or multimer staining. *Peptide PYKRIEELL was identified by nonradioactive cytotoxicity assay for lactate dehydrogenase (LDH) release. The HLA-A, HLA-B and HLA-C genotyping of healthy volunteers that showed responses to HCMV, EBV or influenza, and SARS, HBV, Dengue derived antigenic peptides are shown. The HLA serotyping of the HLA-B15 donor (D16) is also given. HLA alleles for which we report conditional ligands for have been indicated in red. ",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 202,
                    "text": "(Heidecker et al, 2000;",
                    "ref_id": null
                },
                {
                    "start": 203,
                    "end": 222,
                    "text": "Ichiki et al, 2004;",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 223,
                    "end": 241,
                    "text": "Nagata et al, 2005",
                    "ref_id": "BIBREF4"
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}